Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 186.90
+7.60 (4.24%)
At close: Nov 27, 2025
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 5.89 billion as of November 26, 2025. Its market cap has decreased by -58.51% in one year.
Market Cap
5.89B
Enterprise Value
5.73B
Revenue
813.59M
Ranking
n/a
PE Ratio
196.89
Stock Price
186.90
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 5.89B, an increase of 1,483.90%. That is a compound annual growth rate of 23.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 5.65B | -63.33% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | 9.02B | 99.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 115.94B |
| Getinge AB | 57.36B |
| Sectra AB | 54.99B |
| Camurus AB | 36.12B |
| Asker Healthcare Group AB | 35.17B |
| Medicover AB | 34.52B |
| BioArctic AB | 24.71B |
| AddLife AB | 22.26B |